Related references
Note: Only part of the references are listed.Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non–Cystic Fibrosis Bronchiectasis and the Significance ofMycobacterium abscessussubsp.abscessusIsolation duringM. aviumComplex Lung Disease Therapy
Vikramjit Mukherjee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus
Amit Kaushik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Discrimination of Mycobacterium abscessus subsp massiliense from Mycobacterium abscessus subsp abscessus in Clinical Isolates by Multiplex PCR
Kazue Nakanaga et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan
Chien-Wen Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massillense Infection and Inducible Resistance
Go-Eun Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
Jakko van Ingen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis
A. Safdar
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases
Toshiyuki Harada et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
Julie Jarand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium
Chiaki Sano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2011)
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
D. Rebecca Prevots et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
Jonathan E. Moore et al.
BMC PUBLIC HEALTH (2010)
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Gwan-Han Shen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
Yi-Ching Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Antibiotic susceptibility pattern of rapidly growing mycobacteria
R. Gayathri et al.
JOURNAL OF POSTGRADUATE MEDICINE (2010)
In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea
Sunghoon Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases
CA Peloquin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
